Supplements / medicine · 23 Oct 2026
Clinical Highlights from Current Sports Medicine Reports | Q3 2026
Source: ACSM
What the research found
Dr. Vincent highlights the latest clinical research published in Current Sports Medicine Reports. The post Clinical Highlights from Current Sports Medicine Reports | Q3 2026 appeared first on ACSM .
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34